Investors Asset Management of Georgia’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.18M Sell
6,818
-100
-1% -$102K 2.84% 5
2026
Q1
$6.36M Buy
6,918
+27
+0.4% +$27.4K 2.6% 3
2025
Q4
$7.41M Sell
6,891
-20
-0.3% -$19.1K 3.06% 4
2025
Q3
$5.27M Buy
6,911
+25
+0.4% +$18.6K 2.24% 7
2025
Q2
$5.37M Sell
6,886
-105
-2% -$81.6K 2.48% 6
2025
Q1
$5.77M Sell
6,991
-169
-2% -$141K 2.92% 4
2024
Q4
$5.53M Sell
7,160
-440
-6% -$364K 2.69% 5
2024
Q3
$6.73M Sell
7,600
-379
-5% -$341K 3.17% 2
2024
Q2
$7.22M Sell
7,979
-145
-2% -$116K 3.52% 3
2024
Q1
$6.32M Sell
8,124
-770
-9% -$548K 2.97% 4
2023
Q4
$5.17M Buy
8,894
+630
+8% +$368K 2.62% 5
2023
Q3
$4.37M Sell
8,264
-260
-3% -$134K 2.41% 7
2023
Q2
$4M Sell
8,524
-1,510
-15% -$633K 2.06% 9
2023
Q1
$3.45M Sell
10,034
-419
-4% -$141K 1.84% 10
2022
Q4
$3.82M Sell
10,453
-223
-2% -$79.1K 1.99% 9
2022
Q3
$3.45M Sell
10,676
-100
-0.9% -$31.7K 1.78% 8
2022
Q2
$3.49M Sell
10,776
-25
-0.2% -$7.5K 1.81% 9
2022
Q1
$3.09M Hold
10,801
1.56% 12
2021
Q4
$2.98M Sell
10,801
-75
-0.7% -$19K 1.42% 10
2021
Q3
$2.51M Buy
10,876
+16
+0.1% +$3.95K 1.31% 12
2021
Q2
$2.49M Sell
10,860
-125
-1% -$25.1K 1.34% 11
2021
Q1
$2.05M Sell
10,985
-275
-2% -$53.8K 1.19% 17
2020
Q4
$1.9M Sell
11,260
-275
-2% -$41.1K 1.28% 14
2020
Q3
$1.71M Sell
11,535
-25
-0.2% -$3.87K 1.14% 15
2020
Q2
$1.9M Sell
11,560
-75
-0.6% -$11.5K 1.32% 9
2020
Q1
$1.61M Sell
11,635
-2,400
-17% -$330K 1.32% 12
2019
Q4
$1.84M Hold
14,035
1.12% 21
2019
Q3
$1.57M Buy
14,035
+100
+0.7% +$11.1K 1% 21
2019
Q2
$1.54M Hold
13,935
1.04% 23
2019
Q1
$1.81M Sell
13,935
-150
-1% -$18.2K 1.26% 16
2018
Q4
$1.63M Sell
14,085
-120
-0.8% -$13.4K 1.33% 15
2018
Q3
$1.52M Hold
14,205
1.06% 23
2018
Q2
$1.21M Sell
14,205
-50
-0.4% -$4.11K 0.89% 27
2018
Q1
$1.1M Buy
14,255
+117
+0.8% +$9.42K 0.82% 28
2017
Q4
$1.19M Sell
14,138
-259
-2% -$22K 0.85% 27
2017
Q3
$1.23M Sell
14,397
-100
-0.7% -$8.2K 0.91% 25
2017
Q2
$1.19M Buy
14,497
+125
+0.9% +$10.2K 0.82% 25
2017
Q1
$1.21M Buy
14,372
+110
+0.8% +$8.81K 0.84% 28
2016
Q4
$1.05M Buy
14,262
+585
+4% +$43.6K 0.78% 31
2016
Q3
$1.1M Sell
13,677
-133
-1% -$10.6K 0.83% 26
2016
Q2
$1.09M Buy
13,810
+125
+0.9% +$9.41K 0.85% 27
2016
Q1
$985K Buy
13,685
+175
+1% +$13.2K 0.82% 29
2015
Q4
$1.14M Buy
13,510
+50
+0.4% +$4.15K 0.95% 22
2015
Q3
$1.13M Hold
13,460
1.01% 18
2015
Q2
$1.12M Buy
13,460
+75
+0.6% +$5.71K 0.96% 21
2015
Q1
$972K Sell
13,385
-100
-0.7% -$7.12K 0.8% 26
2014
Q4
$930K Buy
+13,485
New +$910K 0.8% 31

Other funds holding LLY

Investors Asset Management of Georgia's LLY Position: Q2 2026 in Review

Investors Asset Management of Georgia reduced its Eli Lilly (LLY) stake by 1.4% in Q2 2026, selling an estimated $102K and leaving 6,818 shares worth $8.18M. The position accounts for 2.84% of the portfolio, ranked #5.

Investors Asset Management of Georgia first reported a position in LLY in Q4 2014 and has held it in 47 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Investors Asset Management of Georgia held 6,818 shares of Eli Lilly worth $8.18M as of Q2 2026.
  • Investors Asset Management of Georgia sold 100 Eli Lilly shares in Q2 2026, an estimated $102K.
  • Eli Lilly made up 2.84% of Investors Asset Management of Georgia's portfolio in Q2 2026, its #5 holding.
  • Investors Asset Management of Georgia first reported a position in Eli Lilly in Q4 2014 and has held it in 47 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Investors Asset Management of Georgia's 13F filing for Q2 2026, filed 22 Jul 2026.